News about DBT

Tran Ngo Minh Anh, born in 2002 and the daughter of Nam A Bank Chairman Tran Ngo Phuc Vu, has been appointed General Director of Ben Tre Pharmaceutical JSC (Bepharco, ticker DBT, HoSE) effective November 1, 2026. She became a board member and Deputy General Director on July 30, 2026, replacing Nguyen Khac Hanh, who resigned after just over three months in the role. She holds a finance degree from the University of Central Florida and worked at New Omni Bank in California, US, during 2024-2026, and she currently owns no DBT shares. DBT also approved a stock dividend issuance at a 7% ratio (100:7), equal to 1.53 million new shares, which would raise charter capital from VND 219.6 billion to nearly VND 235 billion once completed.

Tran Ngo Minh Anh, born in 2002, is the daughter of Tran Ngo Phuc Vu, chairman of the board of Nam A Bank. She was appointed CEO of Ben Tre Pharmaceutical JSC (DBT) from early November, only three months after becoming deputy CEO. The appointment followed the company's approval, on the afternoon of October 23, of the resignation of Nguyen Khac Hanh as CEO. Minh Anh holds a bachelor's degree in finance from the University of Central Florida and worked at New Omni Bank in California, USA, during 2024-2026; she currently holds no DBT shares. In 2025, the company reported revenue of VND 860 billion, and in the first half of this year it reached about VND 420 billion. DBT shares trade around VND 13,000.

Bepharco announced the appointment of Ms. Trần Ngô Minh Anh (24) as general director under a decision dated October 23, 2026, effective November 1, 2026. Ms. Minh Anh earned a finance degree from the University of Central Florida on a scholarship and then spent nearly three years at New Omni Bank (NOB), a California-based bank. She joined Bepharco in August, was elected to the board at the 2026 extraordinary general meeting, and was later named deputy general director before this appointment. Founded in 1963, the pharmaceutical company's shares trade under the ticker DBT.